| Followers | 197 |
| Posts | 13482 |
| Boards Moderated | 0 |
| Alias Born | 06/20/2022 |
Thursday, January 04, 2024 6:29:53 PM
DRMAW (Warrants): Closed UP by 153% today in the OPEN Market --- before the Post-M news even hit (Insiders at work).
Recent DRMA News
- Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System • ACCESS Newswire • 04/02/2026 12:30:00 PM
- Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 • ACCESS Newswire • 03/26/2026 09:15:00 PM
- Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing • ACCESS Newswire • 03/10/2026 12:30:00 PM
- Dermata Opens a New Chapter with the Release of Tome Skincare • ACCESS Newswire • 03/05/2026 02:00:00 PM
- Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office • ACCESS Newswire • 01/20/2026 01:05:00 PM
- Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules • ACCESS Newswire • 12/29/2025 09:05:00 PM
- Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules • ACCESS Newswire • 12/24/2025 01:00:00 PM
- A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity • ACCESS Newswire • 12/04/2025 01:00:00 PM
- Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/14/2025 09:05:00 PM
- Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office • ACCESS Newswire • 10/02/2025 12:00:00 PM
- Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 09/18/2025 12:35:00 PM
- Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th • GlobeNewswire Inc. • 09/16/2025 12:35:00 PM
